G1 Therapeutics, Inc.

Historical 13F Holders

Symbol
GTHX
CUSIP
3621LQ109
All holders as of
Q2 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q2 100 20.4 M $46.4 M
2024 Q1 97 14.7 M $63.3 M
2023 Q4 94 12.8 M $39.0 M
2023 Q3 76 10.9 M $15.6 M
2023 Q2 86 15.5 M $38.6 M
2023 Q1 104 19.2 M $51.7 M
2022 Q4 121 23.2 M $126 M
2022 Q3 107 23.0 M $287 M
2022 Q2 100 19.8 M $98.1 M
2022 Q1 122 24.1 M $184 M
2021 Q4 117 26.7 M $273 M
2021 Q3 123 26.6 M $357 M
2021 Q2 123 24.7 M $541 M
2021 Q1 134 24.2 M $582 M
2020 Q4 141 26.4 M $474 M
2020 Q3 126 29.6 M $343 M
2020 Q2 106 28.8 M $699 M
2020 Q1 105 28.6 M $320 M
2019 Q4 106 30.6 M $809 M
2019 Q3 106 29.0 M $664 M
2019 Q2 103 28.2 M $864 M
2019 Q1 99 27.6 M $458 M
2018 Q4 95 27.7 M $531 M
2018 Q3 123 26.8 M $1.40 B
2018 Q2 96 23.1 M $1.00 B
2018 Q1 95 20.0 M $742 M
2017 Q4 57 13.6 M $270 M
2017 Q3 42 12.3 M $289 M
2017 Q2 27 9.97 M $174 M